These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Rayasam A; Drobyski WR Front Immunol; 2021; 12():779076. PubMed ID: 34899738 [TBL] [Abstract][Full Text] [Related]
47. Inflammatory Cytokine Networks in Gastrointestinal Tract Graft vs. Host Disease. Piper C; Drobyski WR Front Immunol; 2019; 10():163. PubMed ID: 30853956 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of Human Dendritic Cell ER Stress Response Reduces T Cell Alloreactivity Yet Spares Donor Anti-tumor Immunity. Betts BC; Locke FL; Sagatys EM; Pidala J; Walton K; Menges M; Reff J; Saha A; Djeu JY; Kiluk JV; Lee MC; Kim J; Kang CW; Tang CH; Frieling J; Lynch CC; List A; Rodriguez PC; Blazar BR; Conejo-Garcia JR; Del Valle JR; Hu CC; Anasetti C Front Immunol; 2018; 9():2887. PubMed ID: 30574153 [TBL] [Abstract][Full Text] [Related]
49. Preclinical models of acute and chronic graft-versus-host disease: how predictive are they for a successful clinical translation? Zeiser R; Blazar BR Blood; 2016 Jun; 127(25):3117-26. PubMed ID: 26994149 [TBL] [Abstract][Full Text] [Related]
50. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Panoskaltsis-Mortari A; Griese M; Madtes DK; Belperio JA; Haddad IY; Folz RJ; Cooke KR; Am J Respir Crit Care Med; 2011 May; 183(9):1262-79. PubMed ID: 21531955 [TBL] [Abstract][Full Text] [Related]
51. Timing of lymphocyte transfusion and portal clamping for the development of lethal graft-versus-host disease in the rat. Kobayashi E; Enosawa S; Fujimura A; Kamada N; Suzuki S Surg Today; 1998; 28(10):1036-41. PubMed ID: 9786575 [TBL] [Abstract][Full Text] [Related]
52. Pathophysiology of graft-versus-host disease directed to minor histocompatibility antigens. Korngold R Bone Marrow Transplant; 1991; 7 Suppl 1():38-41. PubMed ID: 2043884 [TBL] [Abstract][Full Text] [Related]
53. Interleukin-1 or tumor necrosis factor-alpha antagonists do not inhibit graft-versus-host disease induced across the major histocompatibility barrier in mice. Vallera DA; Taylor PA; Vannice JL; Panoskaltsis-Mortari A; Blazar BR Transplantation; 1995 Dec; 60(11):1371-4. PubMed ID: 8525541 [TBL] [Abstract][Full Text] [Related]
54. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model. Choksi S; Kim JC; Whitaker-Menezes D; Murphy GF; Friedman TM; Korngold R Biol Blood Marrow Transplant; 2004 Oct; 10(10):669-80. PubMed ID: 15389433 [TBL] [Abstract][Full Text] [Related]
55. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Teshima T; Ordemann R; Reddy P; Gagin S; Liu C; Cooke KR; Ferrara JL Nat Med; 2002 Jun; 8(6):575-81. PubMed ID: 12042807 [TBL] [Abstract][Full Text] [Related]
56. The role of TNF in hepatic histopathological manifestations and hepatic CD8+ T cell alloresponses in murine MHC class I disparate GVHD. El-Hayek JM; Rogers TE; Brown GR J Leukoc Biol; 2005 Oct; 78(4):1001-7. PubMed ID: 16081594 [TBL] [Abstract][Full Text] [Related]